Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Find out which credit cards offer rewards without annual fees. Enjoy benefits without the burden of fees!
25,978 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
As 2026 unfolds amid market swings and thinner savings, Suze Orman’s call to delay Social Security to 70 sharpens the...
The February payroll report shows the u.s. economy lost 92,000 jobs, signaling a cooler labor market despite earlier ...
Social Security remains a cornerstone of retirement income, but 2026 brings changes that could affect when and how yo...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
Amundi, Europe's biggest asset manager, launches a UCITS-compliant Solana fund in partnership with SPiko Finance, mar...
Earnings season isn’t fading—it's evolving. This week’s earnings reports watch this picks three widely followed names...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
SpaceX exploded onto the public markets, and the initial gains grabbed headlines. Two veteran analysts share what the...
Caregiving and end-of-life decisions test both hearts and wallets. This article explores practical, compassionate ste...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...